NCT03878303View on ClinicalTrials.gov

Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE)

PHASE1UnknownINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 28, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2021

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

AC0058TA

25 mg capsules

DRUG

Placebo AC0058TA

equivalent dose of investigational product

Trial Locations (1)

75231

RECRUITING

Metroplex Clinical Research Center, Dallas

Sponsors
All Listed Sponsors
collaborator

Hangzhou ACEA Pharmaceutical Research Co., Ltd.

INDUSTRY

lead

ACEA Therapeutics, Inc.

INDUSTRY